If you have been told over the years to "just lose a bit of weight, go on the pill, and come back when you want to get pregnant," you are not alone — and you may already sense how rarely that advice actually helps. In 2026 something happened that could change the whole conversation: the condition we have long called PCOS (polycystic ovary syndrome) has been given a new name. So why does a name matter so much?
Why PCOS became PMOS
On 12 May 2026, an international consensus group published a new name for PCOS in one of the world's most respected medical journals, The Lancet: PMOS — Polyendocrine Metabolic Ovarian Syndrome. This was not a snap decision. The process, led by Professor Helena Teede at Monash University, ran for roughly a decade and gathered the views of tens of thousands of patients, clinicians and researchers. It is best understood not as an overnight, binding rule in every clinic, but as a widely agreed recommendation — one that guidelines and clinics are expected to take a few years to adopt fully.
The "cysts" aren't really cysts
The main reason for the change is simple: the word "polycystic" is misleading. Most women diagnosed with the condition don't actually have dangerous ovarian cysts. What shows up on an ultrasound is usually a cluster of small follicles — part of the normal egg-development process. The 2023 international guideline makes this clear: a diagnosis needs at least two of three features — signs of excess androgens, irregular ovulation, and many follicles on ultrasound or a raised AMH level. For many women, the fear of "having cysts" has been an unnecessary worry.
Why it's really a metabolic picture
The new name highlights that the problem isn't confined to the ovaries — it involves the whole body. Research shows that insulin resistance plays a role in most women who live with the syndrome, and it's linked to stubborn weight gain, blood-sugar swings and a higher risk of type 2 diabetes. According to the World Health Organization, the condition affects around 10–13% of women of reproductive age, and up to 70% of those affected haven't been diagnosed. Irregular periods, acne, excess hair, hair thinning, energy dips and mood changes can all be part of the same picture.
What you can do with food and lifestyle
Here's the encouraging part: lifestyle is one of the most powerful tools for managing this condition. The international guideline recommends diet, movement and behavioural change as the first step for everyone. A few small, sustainable habits:
- Keep blood sugar steady. Lower-GI meals built around wholegrains, pulses, vegetables and enough protein can help support insulin balance.
- Make room for movement. Regular activity improves insulin sensitivity — and the kind you enjoy is the kind you'll keep up.
- Don't overlook sleep and stress. Sleep quality and stress management matter more for hormone balance than they often get credit for.
- Skip the search for a "miracle diet." The guideline notes there isn't enough evidence that any one diet beats another; what matters is a balanced pattern you can sustain.
Evidence for the much-discussed inositol supplement is still limited — some women see small improvements in metabolic markers, but it isn't a treatment on its own. Always check with your doctor before trying a supplement like this.
A new name won't make symptoms disappear on its own — but it changes how we talk. Calling it "a hormonal and metabolic condition affecting the whole body," rather than "a cyst disease," makes both diagnosis and care more joined-up. The goal isn't a magic "cure"; it's managing symptoms and protecting your long-term health.
Prefer to Watch?
I've also covered this topic on my YouTube channel — press play if you'd rather watch than read.
If you have a PCOS/PMOS diagnosis or think you may have symptoms, don't settle for a scan that only checks "are there cysts?" Ask your doctor about a hormone panel, insulin resistance and, if needed, a thyroid check. This article is for general information and isn't a substitute for individualised advice from your own doctor or dietitian.
Merve Tığlı, Dietitian
Sources: The Lancet — Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus (2026); World Health Organization — Polycystic ovary syndrome fact sheet; 2023 International Evidence-based Guideline for the Assessment and Management of PCOS (Monash University / ESHRE).